Combining CT angiography (CTA) and SPECT MPI is useful for the evaluation of coronary artery disease (CAD) and shows more diagnostic benefit than just one of the modalities or consecutive use of the two technologies, according to a study published Jan. 1 in the Journal of Nuclear Medicine.

Breast-specific imaging systems are by far the most sensitive and specific molecular modalities for the visualization of breast tumors, according to a review published Jan. 16 in the Journal of Nuclear Medicine.

New copper-64 and gallium-68 chelating platforms are being developed by Macrocyclics, a subsidiary of AREVA Med, the company announced Jan. 10. Four new formulas would expand the company’s PET imaging portfolio.

A PET/CT study followed 40 sufferers of heart attacks and just as many matched controls imaged with conventional coronary angiography and sodium fluoride PET/CT to gauge vulnerable plaques and see potential risk of heart attack.

A $122 million boon for U.S. Alzheimer’s research funding was signed by President Obama on Jan. 16.

Akili Interactive Labs and Pfizer are partnering to evaluate patients’ risk of developing Alzheimer’s disease by following their performance while playing a specialized video game, Akili announced Jan. 9.

Biopharmaceutical company Intellect Neurosciences announced Jan. 16 that a potentially disease-modifying tau agent is in the preliminary stages of validation for neurological diseases including Alzheimer’s.

A bill that would increase Alzheimer’s research funding appropriations by $122 million has passed Congress and is now under deliberation by the president.